ADDENDUM TO SHARE EXCHANGE AGREEMENT

THIS ADDENEDUM (the "Addendum"),  dated September 16, 2005, shall serve to amend
the below listed terms of the SHARE EXCHANGE  AGREEMENT (the "Agreement")  dated
August 11,  2005,  by and between  Eline  Entertainment  Group,  Inc.,  a Nevada
corporation ("Eline"),  CTD Holdings,  Inc., a Florida corporation ("CTDH"), and
Rick  Strattan   ("Strattan"),   the  President,   CEO,  Chairman  and  majority
shareholder of CTDH, therein removing paragraphs 7 and 11 of the Agreement dated
August 11, 2005 and inserting the respective  paragraphs  listed below as of the
first date listed above.

7.   OPERATION OF CTDH AFTER CLOSING.

     (a) Strattan is the principal  executive  officer of CTDH,  responsible for
its  business  and  operations.  After the Closing,  Strattan  will  continue to
fulfill  those  duties  in the  same  manner  and  with  the  same  devotion  of
substantially   all  of  his  time  and  efforts  in  fulfilling  his  fiduciary
obligations in such capacity.  Strattan shall have  autonomous  control over the
CTD,  Inc.   operating   subsidiary  and  acquisitions   further  expanding  the
cyclodextrin   businesses,   divisions  and  direction,   and   specifically  as
contemplated in paragraph 7(d) herein,  that  autonomous  control shall apply to
all matters  including  day-to-day  operations.  It is understood by all parties
hereto that such autonomous  control is due to Strattan's  extensive  expertise,
contacts and experience in the  cyclodextrin  area and such  autonomous  control
shall apply to the  day-to-day  operations of the  cyclodextrin-based  business.
Further,  CTDH shall  consult with Strattan in all future  acquisitions  by CTDH
prior to closing of such anticipated acquisitions.

     (b) Strattan will submit operating budgets to Eline for its approval, which
such approval will not be  unreasonably  withheld,  and Eline and Strattan shall
agree regarding the hiring or retention of any employees or consultants that are
not involved in the day-to-day operations of the CTDH.

     (c) Effective  with the Closing  Date,  Eline will charge CTDH from time to
time for normal corporate overhead attributable to the administration of CTDH.

     (d)  Subsequent to the Closing Date,  Eline,  at its own  discretion,  will
advance CTDH at various  times and in various  amounts an aggregate of up to one
million five hundred  thousand  dollars  ($1,500,000) to be used by CTDH for the
acquisition  of Cyclolab  R&D Labs of  Budapest,  Hungary.  Such funding is also
subject to the  completion  of  satisfactory  due diligence on the part of Eline
with respect to both Cyclolab R&D Labs and CDTH.

11. DISTRIBUTION OF CDTH BUSINESS OPERATIONS. In conjunction with this agreement
and the  terms  of the  Exchange  of  Shares  pursuant  to  Paragraph  2 and the
Operation of CDTH After Closing  pursuant to Paragraph 7 (d), it is contemplated
that Eline and CDTH will attempt to acquire other businesses  entities operating
in the  cyclodextrin  and bio-tech  industries  that  compliment  or augment the
current  business  operations  of CTDH.  In the event Eline or CTDH is unable to
consummate such  transactions and achieve this goal within one year from date of
the closing herein,  or as otherwise agreed upon between the parties,  Eline, at
its sole  discretion,  may take such actions as may be appropriate to distribute
the business of CTDH to the  stockholders  of CTDH. At Eline's sole  discretion,
such  distribution  shall  be  accomplished  through  one of the  following  two
methods:

     (a) Strattan will return to Eline 100,000  shares of the Eline Common Stock
in  exchange  for the return to  Strattan of the one share of Series A preferred
stock of  CTDH,  which  share  represents  controlling  interest  in the  voting
securities of CTDH, or;

     (b) Eline shall  undertake the creation of a newly formed entity having the
identical  capital  structure of CTDH,  wherein  such newly formed  entity shall
distribute to CDTH  shareholders its common stock on a basis equal to the number
of  shares  held by such  shareholders  in CTDH as of the  record  date for such
distribution,  as well as  distribute  to Strattan  shares of a preferred  stock
having the rights and  preferences  equivalent to those of the share of Series A
preferred stock of CTDH, including controlling interest in the voting securities
of the newly formed entity.  Further,  Eline shall take such steps  necessary to
ensure  that the new  entity  is  publicly  traded  on the OTC  Bulletin  Board,
emulating the current status of CTDH.  Moreover,  Eline shall retain an interest
of 20% of the common stock of such newly formed entity on a fully diluted basis.

     IN WITNESS  WHEREOF,  the parties  hereto have executed this Addendum as of
the date first above written.

                                       ELINE ENTERTAINMENT GROUP, INC.

                                       By:  /s/ Barry A. Rothman
                                       -----------------------------
                                       Barry A. Rothman, President


                                       ELINE HOLDING GROUP, INC.

                                       By:  /s/ Jayme Dorrough
                                       -----------------------------
                                       Jayme Dorrough, Sole Director


                                       CTD HOLDINGS, INC.

                                       By:  /s/ C.E. Rick Strattan
                                       -----------------------------
                                       Rick Strattan, President, CEO & Chairman